EFPIA - NEWSLETTER

EFPIA Newsletter 10 July 2025

News

04 July 2025 EFPIA Position on the Critical Medicines Act

By embedding flexibility, coordination, and proportionate regulation into its implementation, the Act can support a...

Blogs

09 July 2025 Transforming regulatory pathways: A path to swift patient access (Guest Blog)

In today’s fast-paced world of medical advancement, regulatory frameworks have a crucial role to act as a key enabler...

Events

31 OCT 2025

Trials@Home Closing Event 2025 Utrecht, Hybrid

Join the conference on 31 October, dedicated to presenting the project’s recommendations on the conduct of DCTs, featuring...

Learn more →

04 NOV 2025

IHI Brokerage Event 2025 Brussels, Belgium

If you’re interested in future IHI funding opportunities, the IHI Brokerage Event is the ideal place to network and...

Learn more →

What are the trends in pharmaceutical R&D expenditure over time?

What we are reading

EU Health Coalition statement on the Life Sciences Strategy 07 July 2025 (EU Health Coalition)

IHI 2024 In Focus 03 July 2025 (IHI)

The EU Biotech Mandate: A path to global leadership and resilience 03 July 2025 (EU Biotech and Life Sciences Alliance)

‘It’s now or never’ for Europe’s life sciences, EC and pharma insist 03 July 2025 (EU Perspectives)

The race to end HPV ‒ by vaccinating boys and girls 03 June 2025 (Vaccines Today)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶